Graft Patency Analysis of the Right Coronary Artery System
NCT ID: NCT01559350
Last Updated: 2019-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
50 participants
OBSERVATIONAL
2012-01-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Total 224 patients will be enrolled according to the randomization protocol.
Check list
1. Laboratories
2. Quantitative coronary analysis (preoperative)
3. Major adverse cardiac and cerebrovascular event
4. coronary CT (coronary angiography if needed) at discharge, 1, 5, 10 years postoperatively
5. Echocardiogram
5\. Cardiac enzyme
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Saphenous Vein Graft Harvested From Upper Versus Lower Leg in Coronary Artery Bypass Grafting
NCT01974492
A Prospective Randomized Study for Comparison of Y-Composite Grafts
NCT01051986
Radial Artery Versus No-touch Saphenous Vein
NCT06014047
Evaluation of Graft Material in Coronary Artery Bypass Grafting (CABG)
NCT01310725
Vein vs Arterial Grafts for Coronary Artery Bypass Grafting Surgery
NCT02158455
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RGEA group
A right gastroepiploic artery in situ grafting in the right coronary artery system during OPCAB
A right gastroepiploic artery in situ grafting
A right gastroepiploic artery in situ grafting in the right coronary artery system during OPCAB
SVG group
A saphenous vein grafting in the right coronary artery system during OPCAB
A saphenous vein grafting
A saphenous vein grafting in the right coronary artery system during OPCAB
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
A right gastroepiploic artery in situ grafting
A right gastroepiploic artery in situ grafting in the right coronary artery system during OPCAB
A saphenous vein grafting
A saphenous vein grafting in the right coronary artery system during OPCAB
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective surgery
* Isolated off pump CABG
* Age \< 75 years and life expectancy \> 5 years
* Preoperative RGEA diameter \> 1.5mm
* Normal left ventricular function
Exclusion Criteria
* History of upper GI bleeding
* Active gastric or duodenal ulcer
* Body mass index \> 35kg/m2
* Redo surgery
* Presence of varicose vein
* Contraindication for CABG such as malignancy or liver cirrhosis
* Other configuration than RGEA to RCA territory or SVG to RCA territory
20 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Samsung Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Young Tak Lee, MD, PhD
Role: STUDY_DIRECTOR
Samsung Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Samsung Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-11-065
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.